Vancouver-based PHEMI has raised $10 million in funding as it works to expand its sales and marketing capabilities.
The round was led by existing investors CTI Life Sciences Fund (CTI), BDC Capital Healthcare Venture Fund, and Yaletown Partners. The round also welcomed new investors Quark Venture Inc. and GF Securities through the Global Health Sciences Fund.
Phemi develops big data solutions for enterprises, which include built-in privacy, governance, and enterprise-grade management. The company’s flagship product lets organizations access and mine any variety of data at any volume, and enforces access privileges.
View the full article here.